AVXL

NASD Anavex Life Sciences Corp.
Oct 8, 2026 · 1:23 AM ET EOD Market Closed

$1.53 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.53, $0.08 below the day’s high of $1.61

YTD change
-57.02%
vs 20-day SMA
-33.31%
vs 200-day SMA
-53.99%

Price ranges

Previous day
$1.56 $1.71
open $1.66 close $1.60
-$0.06 (-3.61%)
Today
$1.52 $1.61
open $1.57 now $1.53
-$0.04 (-2.55%)
Past week
$1.56 $2.38
from $2.36 now $1.53
-$0.83 (-35.17%)
Past month
$1.56 $2.90
from $2.85 now $1.53
-$1.32 (-46.32%)
This year
$1.52 $5.36
from $3.56 now $1.53
-$2.03 (-57.02%)

Price & Performance

-1.55 (-50.32%) / 6M

$1.36$2.18$3.00$3.82Apr 7Jul 8Oct 7

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 95.1% away from all-time highs of $31.50
  • AVXL is down 57% since the beginning of the year
  • AVXL is down 84% over the past 12 months
  • AVXL is down 46% over the past 1 month
  • 16% of all AVXL investors are betting against AVXL

AVXL reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -84.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.08
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $30.3M
Beta 1.99

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$118.3M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $141.8M

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,188.72 +2.70%
JNJ Johnson & Johnson $258.45 +1.44%
ABBV AbbVie, Inc. $271.36 +1.75%
MRK Merck & Co., Inc. $142.79 +0.60%
RHHBY Roche Holding Ltd Sponsored ADR $54.07 +2.89%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.